Repligen (RGEN) Operating Income Growth (1y) (2011 - 2026)
Repligen (RGEN) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 47.95% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -75.72% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -26.09% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 17.25% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 65.51% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -116.77% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 8.28% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.79% |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 142.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.32% |
| Dec 31, 2025 | 352.94% |
| Sep 30, 2025 | 314.82% |
| Jun 30, 2025 | 154.09% |
| Mar 31, 2025 | 75.41% |
| Dec 31, 2024 | 72.75% |
| Sep 30, 2024 | -266.96% |
| Jun 30, 2024 | -71.64% |
| Mar 31, 2024 | -72.94% |
| Dec 31, 2023 | -153.07% |
| Sep 30, 2023 | -91.09% |
| Jun 30, 2023 | -69.48% |
| Mar 31, 2023 | -76.90% |
| Dec 31, 2022 | 30.47% |
| Sep 30, 2022 | 16.53% |
| Jun 30, 2022 | 30.95% |
| Mar 31, 2022 | 64.91% |
| Dec 31, 2021 | 114.89% |
| Sep 30, 2021 | 115.61% |
| Jun 30, 2021 | 146.92% |